FDA 483 - Lilly del Caribe, Inc - September 21, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Lilly del Caribe Inc. in Carolina, PR, was inspected and received a Form 483 with five observations related to significant deficiencies in their quality control, complaint handling, and manufacturing investigation systems. The observations highlight issues with incomplete laboratory records, unrecorded deviations, inadequate complaint investigations, insufficient documentation of manufacturing discrepancies, and deficient in-process material inspection procedures. These findings indicate a need for improved data integrity, procedural adherence, and comprehensive record-keeping across several critical areas.
ID · ce0b5072-f84a-409e-b147-2a40ff94b035